Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Advantages of Using Selective Laser Capsulotomy to Create Capsulorhexis in Cases Intumescent Cataract

NCT07266844 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT07266844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Advantages of Using Selective Laser Capsulotomy to Create Capsulorhexis in Cases Intumescent Cataract
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Completed
Start date
July 8, 2025
Completion date
November 6, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intumescent cataract